Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study-INTERACT MESO

Job P. Van Kooten, Michelle V. Dietz*, Niels A.D. Guchelaar, Alexandra R.M. Brandt-Kerkhof, Stijn L.W. Koolen, Jacobus W.A. Burger, Ron H.J. Mathijssen, Cornelis Verhoef, Joachim G.J.V. Aerts, Eva V.E. Madsen

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)
2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study-INTERACT MESO'. Together they form a unique fingerprint.

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Chemistry

Biochemistry, Genetics and Molecular Biology